| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 9 |
| 1 | DOCETAXEL | 7 |
| 2 | DOCETAXEL ANHYDROUS | 7 |
| 3 | TRASTUZUMAB | 6 |
| 4 | FULVESTRANT | 5 |
| 5 | ANTI ITCH | 4 |
| 6 | ANTI-ITCH | 4 |
| 7 | ANTI-ITCH CREAM | 4 |
| 8 | ANTI-PRURITIC | 4 |
| 9 | ANTIPRURITIC (ANTI-ITCH) | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIKACIN SULFATE | 1 | 0.0006 |
| 1 | VANDETANIB | 1 | 0.0006 |
| 2 | CLINDAMYCIN PHOSPHATE TOPICAL | 1 | 0.0003 |
| 3 | BRIGATINIB | 1 | 0.0003 |
| 4 | DESMOPRESSIN ACETATE | 1 | 0.0003 |
| 5 | ADO-TRASTUZUMAB EMTANSINE | 2 | 0.0002 |
| 6 | CABERGOLINE | 1 | 0.0002 |
| 7 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 8 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 9 | TOPOTECAN | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 1 | Estrogen Receptor Antagonist [EPC] | 5 | 0.0001 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 6 | 0.0001 |
| 3 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 | 0.0001 |
| 5 | Microtubule Inhibitor [EPC] | 8 | 0.0000 |
| 6 | RANK Ligand Inhibitor [EPC] | 9 | 0.0000 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 8 | Androgen [EPC] | 1 | 0.0000 |
| 9 | Aromatase Inhibitor [EPC] | 3 | 0.0000 |